WALTHAM, Mass.--(BUSINESS WIRE)--Synageva BioPharma announced today the appointment of Mark Goldberg, M.D., Senior Vice President of Clinical Research at Genzyme Corp., and a leading medical oncologist and hematologist, to the Company’s Board of Directors.
